Last update 28 Mar 2025

Brilacidin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Brilacidin (USAN), Brilacidin tetrahydrochloride, Brilacidin-Ocular
+ [5]
Action
inhibitors, enhancers
Mechanism
SARS-CoV-2 antigen inhibitors, Cell membrane permeability enhancers
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC40H50F6N14O6
InChIKeyQPDYBCZNGUJZDK-DNQXCXABSA-N
CAS Registry1224095-98-0

External Link

KEGGWikiATCDrug Bank
D10414Brilacidin-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 2
United States
22 Feb 2021
COVID-19Phase 2
Russia
22 Feb 2021
Head and Neck NeoplasmsPhase 2
United States
14 Aug 2014
MucositisPhase 2
United States
14 Aug 2014
radiation oral mucositisPhase 2
United States
14 Aug 2014
Bacterial InfectionsPhase 2
United States
01 Feb 2014
Skin Diseases, InfectiousPhase 2
United States
01 Feb 2014
Methicillin-Resistant Staphylococcus Epidermidis (MRSE) InfectionPhase 2
Canada
01 Oct 2010
Methicillin-Resistant Staphylococcus Epidermidis (MRSE) InfectionPhase 2
Russia
01 Oct 2010
Methicillin-Resistant Staphylococcus Epidermidis (MRSE) InfectionPhase 2
Ukraine
01 Oct 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
120
Placebo
(Pooled Placebo + SoC)
vqlaakmylm(fjdfafadpp) = xzajdlylzb tqdxtihxco (vjkeozwdkh, qlqdjkdkby - xkofnzbgoc)
-
16 Sep 2022
(Brilacidin 3-dose + SoC)
vqlaakmylm(fjdfafadpp) = qomjfjcomt tqdxtihxco (vjkeozwdkh, jgyvjqrqxv - erendgqqgj)
Phase 2
61
Placebo
(Placebo Oral Rinse)
zawrohtyeb(mklaorgbdk) = oezwcprtas wkcyfykzzi (ycviwdzvjh, xtkwpctxpm - rgohkaqwgx)
-
16 Jan 2019
(Active Oral Rinse)
zawrohtyeb(mklaorgbdk) = gyrpuowhnx wkcyfykzzi (ycviwdzvjh, yxcafctgvg - padpzygcte)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free